Concepedia

Minerva Biotechnologies (United States)

MB

Statistics

Publications

46

Citations

2.1K

Authors

8

Location

Waltham, United States

Minerva Biotechnologies (United States) is a company institution in Waltham, United States known for life sciences, oncology, and cell signaling.

HomepageROR

Top concepts

Publications

46

MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells

Shawn P. Fessler, Mark T. Wotkowicz, S. Mahanta et al. · Breast Cancer Research and Treatment · 2009 · 95 citations

, , +12

MUC1* Mediates the Growth of Human Pluripotent Stem Cells

Sherry T. Hikita, Kenneth S. Kosik, Dennis Clegg et al. · PLoS ONE · 2008 · 78 citations · Full text

, , +17

A Minimal Fragment of MUC1 Mediates Growth of Cancer Cells

S. Mahanta, Shawn P. Fessler, Jae-Hong Park et al. · PLoS ONE · 2008 · 75 citations · Full text

, , +14

Pro‐Regenerative Hydrogel Restores Scarless Skin during Cutaneous Wound Healing

Guoming Sun · Advanced Healthcare Materials · 2017 · 58 citations

, , +17

Differential Proteome Analysis of Extracellular Vesicles from Breast Cancer Cell Lines by Chaperone Affinity Enrichment

Steve Griffiths, Michelle Cormier, Aled Clayton et al. · Proteomes · 2017 · 52 citations · Full text

, , +17

1–5 of 46

Authors

8

  1. CB
    Cynthia Bamdad

    Minerva Biotechnologies (United States), United States

    43 publications · 1.3K citations

    11

    h-index

  2. EJ
    Eric J. Hartman

    Minerva Biotechnologies (United States), United States

    4 publications · 144 citations

    3

    h-index

  3. VM
    Vasilios M. Hatziioannou

    Minerva Biotechnologies (United States), United States

    4 publications · 78 citations

    3

    h-index

  4. KJ
    Kyle J. Bernier

    Minerva Biotechnologies (United States), United States

    3 publications · 54 citations

    2

    h-index

  5. MT
    Mark T. Wotkowicz

    Minerva Biotechnologies (United States), United States

    2 publications · 119 citations

    2

    h-index

1–5 of 8